Full-Time

Senior Regulatory Affairs Specialists

Confirmed live in the last 24 hours

Medtronic

Medtronic

10,001+ employees

Develops and manufactures medical devices and therapies

Compensation Overview

$114.4k - $133.2k/yr

+ Employee Referral Bonus

Senior

Minneapolis, MN, USA

This position is open to telecommuting from anywhere in the United States.

Category
Risk & Compliance
Legal & Compliance
Requirements
  • Master’s degree in Regulatory Affairs, Biomedical Engineering, Chemistry, or closely related field
  • Requires two (2) years’ experience as a Regulatory Affairs Specialist, R&D Engineer or related occupation in Regulatory Affairs / R&D Engineering
  • Experience must include two (2) years post-bachelor’s progressive experience with MDD/MDR design dossiers, technical files and change notifications, and Design History Files for Class I, II and III medical devices
  • Experience with Common Submission Dossier (CSDT), Device master file (DMF) and Japan Shonin
  • Experience with total product life-cycle regulatory activities to include pre-clinical, clinical, approval and post-approval
  • Knowledge of 21 CFR 800,801, 803,814, Japan’s Pharmaceuticals and Medical Devices Act, EU Medical Device Directive 2007/47/EC, EU Medical Device Regulation (EU) 2017/745, Australia’s Therapeutic Goods Administration (TGA) Regulations
  • Knowledge of QSR 21 CFR 820, ASEAN Medical Device Directive (AMDD), CMDR, ISO 13485, and ISO 14971
Responsibilities
  • Develop regulatory strategies
  • Prepare U.S, EU, and international submissions
  • Obtain and maintain approval for products and therapies to markets worldwide for Class I, II and III devices
  • Support Market Expansion and product development teams by preparing regulatory strategies and identifying regulatory requirements for submissions
  • Assess the regulatory impact of changes to cleared & approved products and processes and coordinate the implementation of any resulting regulatory strategy
  • Prepare document packages for regulatory submissions from all areas of company and inspections for FDA Quality Systems Regulation (QSR)
  • Compile all materials required in submissions, license renewal and annual registrations for submissions
  • Recommend changes for labeling, manufacturing, marketing, and clinical protocols for regulatory compliance
  • Communicate with regulatory agencies and Notified Body and serve as regulatory liaison on the project team throughout the product lifecycle
  • Develop MDD and MDR design dossiers, technical files and change notifications and Design History Files for Class I, II and III devices
  • Work on Common Submission Dossier (CSDT), Device master file (DMF) and Japan shonin
  • Responsible for total product life-cycle regulatory activities to include pre-clinical, clinical, approval and post-approval
  • Navigate worldwide regulatory requirements and adhere to regulations including FDA medical device regulations like 21 CFR 800, 801, 803,814, Japan’s Pharmaceuticals and Medical Devices Act, EU Medical Device Directive 2007/47/EC, EU Medical Device Regulation (EU) 2017/745, Australia’s Therapeutic Goods Administration (TGA)
  • Ensure product adherence to government and industry standards including Quality System Regulation (QSR 21 CFR 820), ASEAN Medical Device Directive (AMDD), CMDR, ISO 13485 and ISO 14971

Medtronic provides medical technology and solutions to improve patient care across various health conditions. The company develops and manufactures a wide range of medical devices, including pacemakers, insulin pumps, surgical tools, and neurostimulation devices. These products help diagnose, prevent, and treat chronic diseases. Medtronic's business model focuses on research and development, manufacturing, and sales, ensuring that healthcare providers have access to the latest medical technologies. Unlike many competitors, Medtronic also offers additional services such as training for healthcare professionals and patient management programs, which enhance the effectiveness of their products. The goal of Medtronic is to improve patient outcomes and reduce healthcare costs through comprehensive healthcare solutions.

Company Size

10,001+

Company Stage

IPO

Headquarters

Fridley, Minnesota

Founded

1949

Simplify Jobs

Simplify's Take

What believers are saying

  • Medtronic's acquisition of Bellco expands its renal care solutions portfolio.
  • The Evolut TAVR system shows superior performance in recent clinical trials.
  • Medtronic's 10-year initiative aims to propel 1M students into health tech careers.

What critics are saying

  • Emerging competitors threaten Medtronic's market share in cardiovascular and diabetes sectors.
  • Technological advancements may outpace Medtronic's R&D capabilities, risking product obsolescence.
  • Supply chain vulnerabilities, like semiconductor shortages, could impact device production.

What makes Medtronic unique

  • Medtronic's global presence spans over 150 countries, enhancing its market reach.
  • The company invests heavily in R&D, driving innovation in medical technology.
  • Medtronic offers comprehensive healthcare solutions, including training and technical support.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Sick Leave

Paid Holidays

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Employee Assistance Program

Wellness Program

Company News

Medtronic
Mar 14th, 2025
Medtronic Adds Life-Extending Dialysis Portfolio to Recently Formed Renal Care Solutions Business with Acquisition of Bellco

DUBLIN - February 1, 2016 - Furthering its commitment to improve outcomes, expand therapy access, and optimize costs and efficiencies in end stage renal disease (ESRD), Medtronic plc (NYSE: MDT)...

Business Wire
Mar 11th, 2025
nVent Announces New Executive Leadership Appointments

Gary joins nVent from Medtronic, where he serves as Senior Vice President, Corporate Finance after serving as Interim Chief Financial Officer from August 2024 to March 2025.

Charities.org
Mar 11th, 2025
Sustainability News provided by 3BL

Medtronic named one of the 2025 World's Most Ethical Companies for the third time by Ethisphere.

Medical Device Network
Mar 10th, 2025
Medtronic announces two-year trial outcomes of Evolut TAVR

Medtronic has announced the Small Annuli Randomized To Evolut or SAPIEN (SMART) head-to-head comparative trial's two-year outcomes of the Evolut transfemoral transcatheter aortic valve replacement (TAVR) for aortic stenosis (AS) and small aortic annulus.

DiCardiology
Mar 10th, 2025
Medtronic Presents New Data, Clinical Milestones at CRT 2025

Medtronic presents new data, clinical milestones at CRT 2025.